Cochrane Abstracts
Methylphenidate for children and adolescents with autism spectrum disorder
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Methylphenidate for Children and Adolescents With Autism Spectrum Disorder." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435902/all/Methylphenidate_for_children_and_adolescents_with_autism_spectrum_disorder.
Methylphenidate for children and adolescents with autism spectrum disorder. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435902/all/Methylphenidate_for_children_and_adolescents_with_autism_spectrum_disorder. Accessed January 13, 2025.
Methylphenidate for children and adolescents with autism spectrum disorder. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435902/all/Methylphenidate_for_children_and_adolescents_with_autism_spectrum_disorder
Methylphenidate for Children and Adolescents With Autism Spectrum Disorder [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2025 January 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435902/all/Methylphenidate_for_children_and_adolescents_with_autism_spectrum_disorder.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Methylphenidate for children and adolescents with autism spectrum disorder
ID - 435902
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435902/all/Methylphenidate_for_children_and_adolescents_with_autism_spectrum_disorder
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
